Eupraxia Pharmaceuticals, Inc. · TSX:EPRX
JAMES E. BESSER's stake in Eupraxia Pharmaceuticals, Inc. fell to 4.50% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 13, 2026
JAMES E. BESSER's stake in Eupraxia Pharmaceuticals, Inc. fell to 4.50%, 2,772,341 shares, as a passive investor on Jun 30, 2026. Filed Aug 13, 2026 (Schedule 13G/A).
- Stake
- 4.50%
- Shares
- 2,772,341
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| MANCHESTER MANAGEMENT COMPANY, LLC | 4.30% | 2,634,048 |
| MANCHESTER MANAGEMENT PR, LLC | 4.30% | 2,634,048 |
| MANCHESTER EXPLORER, L.P. | 4.10% | 2,511,121 |
| JAMES E. BESSER | 4.50% | 2,772,341 |
| MORGAN C. FRANK | 4.30% | 2,664,780 |
Source
Related
- Eupraxia Pharmaceuticals, Inc.
- James E. Besser
- Eupraxia Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · James E. Besser · May 12, 2026
- Schedule 13G/A · James E. Besser · Feb 17, 2026
- Schedule 13G · James E. Besser · Nov 13, 2025
- Schedule 13D/A · Joseph S. Freedman · Mar 16, 2026
- Schedule 13G/A · Robert Disbrow · Nov 14, 2025
- Schedule 13G · Beutel, Goodman & Co Ltd. · Nov 14, 2025
- Schedule 13D/A · Joseph S. Freedman · Sep 26, 2025